<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03112356</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL16_0728</org_study_id>
    <nct_id>NCT03112356</nct_id>
  </id_info>
  <brief_title>The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials</brief_title>
  <acronym>PLEIM</acronym>
  <official_title>The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infectious endocarditis is a serious pathology with difficult diagnosis especially on
      prosthetic valves or cardiac device because of the plurality of clinical presentations and
      the low sensitivity value of echocardiography in these patients. Despite a well validated
      indication for the detection of septic emboli, the value of FDG-PET for the detection of
      prosthetic valves or cardiac implantable device is still unclear especially because of
      frequent non-septic inflammatory processes.

      To improve the specificity value, the use of radio-labeled leukocytes scintigraphy is
      conventionally proposed. An alternative method is to label leukocytes in vivo with an
      anti-murin anti body fragment ( Sulesomab , Leukoscan®). This scintigraphy is regularly used
      in the investigation of osteomyelitis and has been proposed in infectious endocarditis. To
      knowledge of investigators, the value of Leukoscan® scintigraphy on prosthetic valve or
      cardiac device infection had not been studied.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 14, 2017</start_date>
  <completion_date type="Anticipated">October 14, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 14, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence or not of infectious endocarditis on surgical materials</measure>
    <time_frame>3 months (plus or minus 1 month)</time_frame>
    <description>The presence or not of infectious endocarditis on surgical materials will be measured using Duke's criteria of patients follow-up at 3 months (plus or minus 1 month).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Endocarditis</condition>
  <arm_group>
    <arm_group_label>99mTc-Leukoscan® scintigraphy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients presenting a suspicions of infectious endocarditis on surgical materials and undergoing the 99mTc-Leukoscan® scintigraphy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>99mTc-Leukoscan® scintigraphy</intervention_name>
    <description>Gated single photon emission computed tomography with co-registered computer tomography (gated SPECT-CT) 6 hours and 24 hours after infusion of 99mTc-Leukoscan (1000 MBq)</description>
    <arm_group_label>99mTc-Leukoscan® scintigraphy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female subjects aged &gt; 21 years

          -  Patients presenting a suspicions of infectious endocarditis on surgical materials

          -  Written informed consent

        Exclusion Criteria:

          -  Patient with a history of exposure to murine antigens, particularly a patient who has
             already received a 99mTc-Leukoscan® scintigraphy

          -  Patients whose clinical condition requires prompt care, not allowing them to wait for
             the examination

          -  Pregnant or nursing (including pumping for storage and feeding)

          -  Patients under adapted antibiotic therapy for more than 15 days

          -  Deprivation of civil rights (curatorship, guardianship, safeguard of justice)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bastien GREGOIRE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bastien GREGOIRE, MD</last_name>
    <phone>472357629</phone>
    <phone_ext>+33</phone_ext>
    <email>bastien.gregoire@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nawele BOUBLAY</last_name>
    <phone>427856302</phone>
    <phone_ext>+33</phone_ext>
    <email>nawele.boublay@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bastien GREGOIRE, MD</last_name>
      <phone>472357629</phone>
      <phone_ext>+33</phone_ext>
      <email>bastien.gregoire@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Nawele BOUBLAY</last_name>
      <phone>427856302</phone>
      <phone_ext>+33</phone_ext>
      <email>nawele.boublay@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Bastien GREGOIRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>François DELAHAYE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline MOREAU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Géraldine PINAJOMIR, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>infectious endocarditis</keyword>
  <keyword>prosthetic valve infection</keyword>
  <keyword>implantable cardiac device infection</keyword>
  <keyword>99mTc-Leukoscan® scintigraphy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Endocarditis</mesh_term>
    <mesh_term>Endocarditis, Subacute Bacterial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

